This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Stocks Fall Ahead of a Potentially Pivotal Stretch
by Benjamin Rains
The market pulled back on Monday ahead of a big week that includes earnings reports from Wall Street giants like JPMorgan and June's CPI data...
What Lies Ahead for Dow ETF in Q2 Earnings?
by Sweta Killa
With some of the blue-chip companies expected to report an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.
Should Vanguard Mega Cap Value ETF (MGV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MGV
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $514.38 in the latest trading session, marking a -0.18% move from the prior day.
Is Most-Watched Stock UnitedHealth Group Incorporated (UNH) Worth Betting on Now?
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Highlights Assertio Holdings, Brookfield Infrastructure, UnitedHealth and General Mills.
by Zacks Equity Research
Assertio Holdings, Brookfield Infrastructure, UnitedHealth and General Mills are part of Zacks top Analyst Blog.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA
Beat the Market Like Zacks: Assertio, Brookfield, UnitedHealth, General Mills in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
Universal Health (UHS) Cuts Guidance, Falls 6.1%: What's Ahead?
by Zacks Equity Research
Universal Health's (UHS) acute care hospitals experience lower-than-expected patient volumes in the second quarter, inducing a decline in revenues and profits.
Patterson Companies (PDCO) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal fourth-quarter 2022 results benefit from strength in the Dental and Animal Health segments.
Humana Inc. (HUM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Humana (HUM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $508.44 in the latest trading session, marking a +0.55% move from the prior day.
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
Top Stock Picks for Week of June 27, 2022
by Panel Of Zacks Experts
A Healthcare Provider and Energy Stock Worth Looking Into.
The Zacks Analyst Blog Highlights UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt
by Zacks Equity Research
UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt are part of Zacks top Analyst Blog.
Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX), and AstraZeneca PLC (AZN).
Select Medical (SEM), Inova Health Form JV in Northern Virginia
by Zacks Equity Research
The JV between Select Medical (SEM) and Inova Health System is expected to own and operate a new 32-bed critical illness recovery facility.
UnitedHealth Group (UNH) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Why You Should Retain Humana (HUM) in Your Portfolio Now
by Zacks Equity Research
Humana's (HUM) strategic acquisitions help it boost its footprint and expand the product portfolio.
UnitedHealth (UNH) Unit Unveils Solution to Provide Better Care
by Zacks Equity Research
UnitedHealth's (UNH) subsidiary Optum introduces a solution that can detect tests that are clinically backed, thereby minimizing unrequired tests and offering enhanced care to health plan members.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $489.68 in the latest trading session, marking a +1.95% move from the prior day.
Centene (CNC) Stock Jumps 6%: Will It Continue to Soar?
by Zacks Equity Research
Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
UnitedHealth (UNH) Unit Eyes $1.5B EMIS Acquisition in UK
by Zacks Equity Research
UnitedHealth's (UNH) Optum business operates in the United Kingdom for two decades and the acquisition is expected to boost its footprint in the country.